Open access peer-reviewed chapter

Introductory Chapter: Overview on Echinococcosis

Written By

Tonay Inceboz

Submitted: July 20th, 2017Reviewed: August 14th, 2017Published: November 15th, 2017

DOI: 10.5772/intechopen.70583

Chapter metrics overview

1,455 Chapter Downloads

View Full Metrics

1. Overview on echinococcosis

Echinococcosis is a zoonotic helminth disease. First, description goes back to 1684 when Francesco Redi has first described the scolex. Then, in 1700s, Philip Jacob Hartmann has defined in an adult form. Since intercontinental travelling is very common, it has been an important health problem in the last decades. Although it has been known for many years, it keeps its peculiarity [13].

Echinococcusbelongs to Cestoda (class) and the Taeniidae (family). There are four most common species: Echinococcus granulosus, Echinococcus multilocularis, Echinococcus vogeliand Echinococcus oligarthrus. The most common one is E. granulosus, causing cystic echinococcosis (CE), whereas E. vogeliis the rarest species. E. multilocularisis also rare; however, it is the most violent species causing alveolar echinococcosis (AE). E. vogeliand E. oligarthruscause polycystic echinococcosis (PE). There are other species of Echinococcus; Echinococcus canadensis, Echinococcus equinus, Echinococcus ortleppiand Echinococcus shiquicus. There are also many different genotypes of each species; E. granulosushas 10 genotypes (G1–G10), whereas E. multilocularishas two genotypes (M1–M2) [4, 5].

Echinococcosis is very widely distributed in all over the world; CE is found in North Pole, Asia, Europe, Africa, Australia and South America. AE is found in Alpine and sub-Arctic or Arctic regions, including Canada, the United States and Central and Northern Europe, China and Central Asia. PE is found in Central and South America [4, 6, 7].

Humans are not definitive hosts; however, two forms of echinococcosis important in humans are CE and AE. Although most people with the disease are asymptomatic, CE causes slowly growing cysts in the liver, lungs and other organs that can be undiagnosed for many years. AE, however, poses a much greater risk than CE, causing parasitic tumors in many organs and can be fatal, if left untreated [4, 6].

The diagnosis of echinococcosis is based on clinical findings, pathology, imaging and serology. There are numerous diagnostic methods for lab diagnosis of echinococcosis. The diagnosis of echinococcosis is based on clinical findings, imaging (radiology, ultrasonography, computed axial tomography, magnetic resonance imaging) [8, 9] and serology tests such as indirect hemagglutination (IHA) [10], enzyme-linked immunosorbent assay (ELISA), IgG-ELISA [1113] or IgE-ELISA [14], immunoblotting (IB), Western blot 7 kDa and/or 18 kDa for CE and 28 kDa for AE [15] and E. multilocularisfor diagnosis of Em2plus-ELISA [16], Em18 [17, 18], Em70 and Em90 [19]. On the other hand, various techniques such as random amplification of polymorphic DNA (PCR-RAPD), restriction fragment length polymorphism (PCR-RFLP) [20, 21] and multiplex PCR for a quick identification were used to determine genetic variations [22, 23].

Therapy for echinococcosis depends on the size, location and symptoms of the cysts and the overall health of the patient. There are medical and surgical approaches; however, medical approach—basically albendazole—is a neoadjuvant and adjuvant therapy. It reduces the risk of recurrent disease by the inactivation of the protoscolices. Surgery is the principle treatment modality [24, 25].

References

  1. 1.Redi F. Osservazioni intorno agli animal viventi che si trouvano negli animali viventi. Firenze: Piero Matini; 1684. p. 244
  2. 2.David I. Grove. A History of Human Helminthology. Wallingford, Oxon: CAB International, 1990. p. viii + 848. ISBN: 0-85198-689-7. DOI:10.1017/S0007087400027965
  3. 3.Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM, Schantz PM. Prevention and control of cystic echinococcosis. Lancet Infectious Diseases. 2007;7(6):385-394. DOI: 10.1016/S1473-3099(07)70134-2
  4. 4.World Health Organization. About Echinococcosis. Available from:http://www.who.int/echinococcosis/about_disease/en/
  5. 5.Alvarez Rojas CA, Romig T, Lightowlers MW.Echinococcus granulosussensu lato genotypes infecting humans—Review of current knowledge. International Journal for Parasitology. 2014;44:9-18. DOI: 10.1016/j.ijpara.2013.08.008
  6. 6.Sachar S, Goyal S, Sangwan S. Uncommon locations and presentations of hydatid cyst. Annals of Medical and Health Sciences Research. 2014;204:447-452. DOI: 10.4103/2141-9248.133476
  7. 7.Hotez PJ, Gurwith M. Europe’s neglected infections of poverty. International Journal of Infectious Diseases. 2011;15:e611-e619. DOI: 10.1016/j.ijid.2011.05.006
  8. 8.Moro P. Clinical Manifestations and Diagnosis of Echinococcosis. UpToDate. Last updated 2017. Available from:http://www.uptodate.com/contents/clinical-manifest-ations-and-diagnosis-of-echinococcosis
  9. 9.Inceboz T, Goktay Y, Sagol O, Korkmaz M, Uner A. Mesenteric Doppler ultrasonography findings ofEchinococcus multilocularisinfection: An experimental study. Türkiye Parazitolojii Dergisi. 2009;33(2):151-154 PubMed PMID: 19598092
  10. 10.Auer H, St€ockl C, Suhendra S, Schneider R. Sensitivity and specificity of new commercial tests for the detection of specific Echinococcus antibodies. Wiener Klinische Wochenschrift. 2009;121:37e41. DOI: 10.1007/s00508-009-1233-4
  11. 11.Zhang W, McManus DP. Recent advances in the immunology and diagnosis of echinococcosis. FEMS Immunology and Medical Microbiology. 2006;47:24e41. DOI: 10.1111/j.1574- 695X.2006.00060.x
  12. 12.Carmena D, Benito A, Eraso E. Antigens for the immunodiagnosis ofEchinococcus granulosusinfection: An update. Acta Tropica. 2006;98:74e86. DOI: 10.1016/j.actatropica.2006.02.002
  13. 13.Sarkari B, Rezaei Z. Immunodiagnosis of human hydatid disease: Where do we stand? World Journal of Methodology. 2015;26;5(4):185-195. DOI: 10.5662/wjm.v5.i4.185
  14. 14.Lawn SD, Bligh J, Craig PS, Chiodini PL. Human cystic echinococcosis: Evaluation of post-treatment serologic follow-up by IgG subclass antibody detection. The American Journal of Tropical Medicine and Hygiene. 2004;70:329e335 PMID: 15031526
  15. 15.Liance M, Janin V, Bresson-Hadni S, Vuitton AD, Houın R, Piarroux R. Immunodiagnosis of echinococcus infections: Confirmatory testing and species differentiation by a new commercial western blot. Journal of Clınical Microbiology. 2000;38(10):3718-3721 PMID: 11015390
  16. 16.Gottstein B, Jacquıer P, Bresnon-Hadni S, Eckert J. Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked Immunosorbent assay using the Em2Plus antigen. Journal of Clinical Microbiology. 1993;31(2):373-376 PMID: 8432825
  17. 17.Bart JM, Piarroux M, Sako Y, Grenouillet Bresson-Hadni S, Piarroux R, Ito A. Comparison of several commercial serologic kits and Em18 serology for detection of human alveolar echinococcosis. Diagnostic Microbiology and Infectious Disease. 2007;59:93-95. DOI: 10.1016/j.diagmicrobio.2007.03.018
  18. 18.Ito A, Xiao N, Liance M, Sato MO, Sako Y, Mamuti W, Ishikawa Y, Nakao M, Yamasaki H, Nakaya K, Bardonnet K, Bresson-Hadni S, Vuitton DA. Evaluation of an enzyme-linked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: Results of a blind test. Journal of Clinical Microbiology. 2002;40:4161e4165 PMID: 12409391
  19. 19.Korkmaz M, Inceboz T, Celebi F, Babaoglu A, Uner A. Use of two sensitive and specific immunoblot markers, Em70 and Em90, for diagnosis of alveolar echinococcosis. Journal of Clinical Microbiology. 2004;42:3350e3352. DOI: 10.1128/JCM.42.7.3350-3352.2004
  20. 20.Bowles J, McManus DP. Rapid discrimination of echinococcus species and strains using a polymerase chain reaction-based RFLP method. Molecular and Biochemical Parasitology. 1993;57:231e239 PMID: 8094539
  21. 21.Xiao N, Nakao M, Qiu J, Budke CM, Giraudoux P, Craig PS, Ito A. Dual infection of animal hosts with different Echinococcus species in the eastern Qinghai-Tibet plateau region of China. The American Journal of Tropical Medicine and Hygiene. 2006;75:292e294 PMID: 16896135
  22. 22.Boubaker G, Macchiaroli N, Prada L, Cucher MA, Rosenzvit MC, Ziadinov I, Deplazes P, Saarma U, Babba H, Gottstein B, Spiliotis M. A multiplex PCR for the simultaneous detection and genotyping of theEchinococcus granulosuscomplex. PLoS Neglected Tropical Diseases. 2013;7:e2017. DOI: 10.1371/journal.pntd.0002017
  23. 23.Can H, Inceboz T, Caner A, Atalay Şahar E, Karakavuk M, Döşkaya M, Çelebi F, Değirmenci Döşkaya A, Gülçe İz S, Gürüz Y, Korkmaz M. Detection ofEchinococcus granulosusandEchinococcus multilocularisin cyst samples using a novel single tube multiplex real-time polymerase chain reaction. Mikrobiyoloji Bülteni. 2016;50(2):266-277 Turkish PubMed PMID: 27175499
  24. 24.McManus DP, Gray DJ, Zhang W, Yang Y. Diagnosis, treatment, and management of echinococcosis. British Medical Journal. 2012;344:e3866. PMID: 22689886. DOI: 10.1136/bmj.e3866
  25. 25.Kern P. Clinical features and treatment of alveolar echinococcosis. Current Opinion in Infectious Diseases. 2010;23:505-512. DOI: 10.1097/QCO.0b013e32833d7516

Written By

Tonay Inceboz

Submitted: July 20th, 2017Reviewed: August 14th, 2017Published: November 15th, 2017